Medtronic (MDT)
(Delayed Data from NYSE)
$89.34 USD
-0.13 (-0.15%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $89.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for Medtronic PLC falls in the month of April.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,705.00 | 3,784.00 | 5,062.00 | 3,630.00 | 4,806.00 |
Depreciation/Amortization & Depletion | 2,647.00 | 2,697.00 | 2,707.00 | 2,702.00 | 2,663.00 |
Net Change from Assets/Liabilities | -484.00 | -967.00 | -889.00 | -701.00 | 61.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 919.00 | 525.00 | 466.00 | 609.00 | -296.00 |
Net Cash From Operating Activities | 6,787.00 | 6,039.00 | 7,346.00 | 6,240.00 | 7,234.00 |
Property & Equipment | -1,587.00 | -1,459.00 | -1,368.00 | -1,355.00 | -1,213.00 |
Acquisition/ Disposition of Subsidiaries | -211.00 | -1,867.00 | -91.00 | -994.00 | -488.00 |
Investments | -307.00 | -171.00 | -190.00 | -463.00 | -1,465.00 |
Other Investing Activities | -261.00 | 4.00 | -10.00 | -54.00 | -37.00 |
Net Cash from Investing Activities | -2,366.00 | -3,493.00 | -1,659.00 | -2,866.00 | -3,203.00 |
Uses of Funds
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | 4/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1,854.00 | -337.00 | -2,115.00 | -178.00 | -664.00 |
Issuance (Repayment) of Debt | 0.00 | -603.00 | -1.00 | -195.00 | -542.00 |
Increase (Decrease) Short-Term Debt | 1,073.00 | 5.00 | 0.00 | -375.00 | -17.00 |
Payment of Dividends & Other Distributions | -3,666.00 | -3,616.00 | -3,383.00 | -3,120.00 | -2,894.00 |
Other Financing Activities | -3.00 | -409.00 | 163.00 | -268.00 | -81.00 |
Net Cash from Financing Activities | -4,450.00 | -4,960.00 | -5,336.00 | -4,136.00 | -4,198.00 |
Effect of Exchange Rate Changes | -230.00 | 243.00 | -231.00 | 215.00 | -86.00 |
Net Change In Cash & Equivalents | -259.00 | -2,171.00 | 121.00 | -547.00 | -253.00 |
Cash at Beginning of Period | 1,543.00 | 3,714.00 | 3,593.00 | 4,140.00 | 4,393.00 |
Cash at End of Period | 1,284.00 | 1,543.00 | 3,714.00 | 3,593.00 | 4,140.00 |
Diluted Net EPS | 2.76 | 2.82 | 3.73 | 2.66 | 3.54 |
Fiscal Year End for Medtronic PLC falls in the month of April.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 1,049.00 | 3,705.00 | 3,045.00 | 1,708.00 | 797.00 |
Depreciation/Amortization & Depletion | 662.00 | 2,647.00 | 1,993.00 | 1,344.00 | 672.00 |
Net Change from Assets/Liabilities | -905.00 | -484.00 | -1,408.00 | -1,918.00 | -823.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 180.00 | 919.00 | 380.00 | 402.00 | 229.00 |
Net Cash From Operating Activities | 986.00 | 6,787.00 | 4,010.00 | 1,536.00 | 875.00 |
Property & Equipment | -520.00 | -1,587.00 | -1,161.00 | -815.00 | -354.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -211.00 | -74.00 | -22.00 | 0.00 |
Investments | 278.00 | -307.00 | -280.00 | -67.00 | -168.00 |
Other Investing Activities | -17.00 | -261.00 | -155.00 | -59.00 | -17.00 |
Net Cash from Investing Activities | -259.00 | -2,366.00 | -1,670.00 | -963.00 | -539.00 |
Uses of Funds
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2,403.00 | -1,854.00 | -304.00 | -229.00 | -75.00 |
Issuance (Repayment) of Debt | 3,209.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -624.00 | 1,073.00 | 1,010.00 | 1,321.00 | 500.00 |
Payment of Dividends & Other Distributions | -898.00 | -3,666.00 | -2,753.00 | -1,836.00 | -918.00 |
Other Financing Activities | -15.00 | -3.00 | -44.00 | 153.00 | -8.00 |
Net Cash from Financing Activities | -731.00 | -4,450.00 | -2,091.00 | -591.00 | -501.00 |
Effect of Exchange Rate Changes | 31.00 | -230.00 | -170.00 | -214.00 | -39.00 |
Net Change In Cash & Equivalents | 27.00 | -259.00 | 80.00 | -232.00 | -204.00 |
Cash at Beginning of Period | 1,284.00 | 1,543.00 | 1,543.00 | 1,543.00 | 1,543.00 |
Cash at End of Period | 1,311.00 | 1,284.00 | 1,623.00 | 1,311.00 | 1,339.00 |
Diluted Net EPS | 0.80 | 0.50 | 0.99 | 0.68 | 0.59 |